2026 UVA Multidisciplinary Aortic Symposium

Save the date! Registration opens soon!

This multidisciplinary symposium will explore the full continuum of care for patients with aortic dissection and connective tissue disorders and features experts from cardiac surgery, vascular surgery, interventional radiology, genetics, cardiology, nursing, advanced practice providers, rehabilitation, mental health, and pharmacy. Through case-based discussions, debates, and evidence-driven updates, participants will examine emerging surgical and endovascular treatments-including Type A dissection management, Endo-Bentall procedures, aortic arch repair, and TEVAR versus fenestration strategies-as well as best practices in medical therapy, hypertension management, and long-term surveillance. Special focus will be placed on connective tissue disorders such as Marfan, Loey's-Dietz, and Ehlers-Danlos syndromes. The symposium will highlight coordinated care across inpatient, outpatient, and community settings strengthens outcomes. Attendees will gain practical insights into optimizing postoperative management, developing comprehensive care pathways, supporting patients' mental health needs, and advancing collaborative, patient-centered aortic disease care throughout the healthcare continuum.

Saturday, May 30, 2026, 7:30 AM - 4:45 PM ET, UVA Pinn Hall Conference Center, Charlottesville, VA

1. Differentiate between open, endovascular, and hybrid approaches for type A and B aortic dissection, including arch repair and Endo-Bentall procedures.
2. Debate the indications, risks, and benefits of TEVAR versus fenestration, incorporating anatomical, clinical, and patient factors.
3. Describe the full healthcare continuum for patients with connective tissue disorders including EDS, Marfan, and Loey’s-Dietz.
4. Incorporate the patient perspective, mental health awareness, and psychosocial support strategies into clinical care.
5. Apply postoperative care pathways for open aortic repair, with emphasis on APP-led surveillance and complication recognition.
6. Implement evidence-based pharmacologic strategies for hypertension and long-term medical management of aortic disease.

AMA PRA Category 1 Credits™ (5.75 hours), AAPA (5.75 hours), ANCC Contact Hours (5.75 hours), Hours of Participation (5.75 hours), IPCE (5.75 hours)

UVA Health CE Cancellation Policy: Cancellation requests received in writing no less than 30 days before the course will be refunded, less a 20% administrative fee. No refunds will be provided for cancellation requests received within 30 days or for registration fees of less than $50.  Please send cancellation requests [email protected]. UVA Health Continuing Education reserves the right to cancel CE activities if necessary.  In this case, the entire registration fee will be refunded.  All other expenses incurred in conjunction with this CE activity are the sole responsibility of the participant.

In support of improving patient care, UVA Health Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Discounted hotel accommodations are available at the Courtyard Marriott – UVA Medical Center, 1201 West Main Street, Charlottesville, VA.

Reserve your room now online to receive the discounted conference room rate of $249 plus tax. Guest parking is $10/day.

To receive the group rate, be sure to make your reservation by April 28^th. The group rate will be available until this date unless the block of rooms sells out early.

Book your group rate for UVA Aortic Symposium 

Mitigation of Relevant Financial Relationships

UVA Health Continuing Education adheres to the Joint Accreditation Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

To view financial disclosures, select the faculty name below.